Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.

Ferreira LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, Neves AF, Nasciutti LE, Goulart LR, Gimba ER.

BMC Cancer. 2012 Nov 6;12:507. doi: 10.1186/1471-2407-12-507.

2.

Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.

Tilli TM, Mello KD, Ferreira LB, Matos AR, Accioly MT, Faria PA, Bellahcène A, Castronovo V, Gimba ER.

Prostate. 2012 Nov;72(15):1688-99. doi: 10.1002/pros.22523. Epub 2012 Apr 11.

PMID:
22495819
3.

Osteopontin-c splicing isoform contributes to ovarian cancer progression.

Tilli TM, Franco VF, Robbs BK, Wanderley JL, da Silva FR, de Mello KD, Viola JP, Weber GF, Gimba ER.

Mol Cancer Res. 2011 Mar;9(3):280-93. doi: 10.1158/1541-7786.MCR-10-0463. Epub 2011 Jan 24.

Supplemental Content

Loading ...
Support Center